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Abstract
Background: Status epilepticus (SE) induces severe vasogenic edema in the piriform cortex (PC) accompanied by
neuronal and astroglial damages. To elucidate the mechanism of SE-induced vasogenic edema, we investigated
the roles of tumor necrosis factor (TNF)-a in blood-brain barrier (BBB) disruption during vasogenic edema and its
related events in rat epilepsy models provoked by pilocarpine-induced SE.
Methods: SE was induced by pilocarpine in rats that were intracerebroventricularly infused with saline-, and
soluble TNF p55 receptor (sTNFp55R) prior to SE induction. Thereafter, we performed Fluoro-Jade B staining and
immunohistochemical studies for TNF-a and NF-B subunits.
Results: Following SE, most activated microglia showed strong TNF-a immunoreactivity. In addition, TNF p75
receptor expression was detected in endothelial cells as well as astrocytes. In addition, only p65-Thr435
phosphorylation was increased in endothelial cells accompanied by SMI-71 expression (an endothelial barrier
antigen). Neutralization of TNF-a by soluble TNF p55 receptor (sTNFp55R) infusion attenuated SE-induced
vasogenic edema and neuronal damages via inhibition of p65-Thr435 phosphorylation in endothelial cells.
Furthermore, sTNFp55R infusion reduced SE-induced neutrophil infiltration in the PC.
Conclusion: These findings suggest that impairments of endothelial cell functions via TNF-a-mediated p65-Thr 485
NF-B phosphorylation may be involved in SE-induced vasogenic edema. Subsequently, vasogenic edema results
in extensive neutrophil infiltration and neuronal-astroglial loss.
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Background
Status epilepticus (SE) is a medical emergency with sig-
nificant mortality [1]. SE has been defined as continuous
seizure activity, which causes neuronal cell death, epi-
leptogenesis and learning impairment [2,3]. Some brain
r e g i o n sv u l n e r a b l et oS Ep l a yar o l ei nt h eg e n e r a t i o n
and propagation of paroxysmal activity in experimental
epilepsy models. The piriform cortex (PC) is one of the
most susceptible brain regions to seizure-induced
damage in the kainate, pilocarpine and other models of
temporal lobe epilepsy (TLE) [4-6]. Pilocarpine, a choli-
nergic agonist, induces SE in rodents. This pilocarpine-
induced SE, similar to human TLE, shows massive neu-
ronal loss in the hippocampus followed by glial prolif-
eration. This neuronal damage in the pilocarpine model
is not restricted to the hippocampus, but often extends
to extrahippocampal limbic structures. Indeed,
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damages within layers II and III of the PC [5,6].
SE also induces severe vasogenic edema in the PC
accompanied by neuronal and astroglial damages [5-8].
Brain edema proceeds in two phases, early cytotoxic edema
phase and late vasogenic edema phase. Early cytotoxic
osmotic edema is due to excess stimulation of glutamater-
gic pathways during SE, which increases intracellular Na
+
and Ca
2+ concentrations. The vasogenic edema results
from dysfunction of endothelial cells and the blood-brain
barrier (BBB). Many studies have reported increased per-
meability of the BBB during epileptic activity [9-13]. A fast
and significant increase in systemic blood pressure, particu-
larly shown during tonic epileptic seizures, induces a
marked vasodilation of the large cerebral arteries and an
increase in blood pressure in capillaries, small arteries, and
veins leading to leakage of the BBB [9]. Loss of BBB integ-
rity is not only due to an abrupt increase in the intralum-
inal pressure but also influenced by the properties of
cerebral tissue. Indeed, an acute increase in blood pressure
or epileptic activity causes an increase in pinocytosis at the
level of the cerebral endothelium [11-13].
Recently, reports have also emphasized that seizure or
epilepsy is a prolonged inflammatory condition, and that
seizure activity rapidly increases the synthesis and
release of various interleukins in rodent brain areas
involved in seizure onset and their generalization. Cyto-
kines act on endothelial cells and change the permeabil-
ity of the BBB, which exerts significant effects on
neuronal viability and excitability [14,15]. Indeed, Sztriha
[16] reported that dexamethasone pretreatment reduces
vasogenic edema in thalamus following kainic acid-
induced seizure. Among cytokines, tumor necrosis fac-
tor-a (TNF-a) is a 17 kDa protein that is produced
mainly by activated macrophages and T cells in the
immune system. TNF-a is expressed at low levels in
normal brain and is rapidly upregulated in glia, neurons
and endothelial cells in various pathophysiological con-
ditions, including SE [17,18]. TNF-a shows various
effects on brain function depending on its local tissue
concentration, the type of target cells, and especially the
specific receptor subtype: TNF receptor I, or p55 recep-
tor (TNFp55R); and TNF receptor II, or p75 receptor
(TNFp75R) [19]. Furthermore, TNF-a induces macro-
phage inflammatory protein-2 (MIP-2) that recruits neu-
trophils under pathological conditions, including SE
[14,20]. Neurons, microglia, and astrocytes produce
MIP-2 when incubated with pro-inflammatory cytokines
such as TNF-a and/or interleukin-1b (IL-1b)o ra f t e r
injury [21-23]. Indeed, we have recently reported that
SE-mediated MIP-2 expression is relevant to leukocyte
infiltrations following SE in an IL-1b-independent man-
ner [20]. However, the relationship between the TNF-a
system and BBB disruption/neutrophil infiltration during
vasogenic edema formation induced by epileptogenic
insults has not been fully clarified. Therefore, in the pre-
sent study, we investigated the roles of TNF-a in vaso-
genic edema and its related events in rat epilepsy
models provoked by pilocarpine-induced SE.
Methods
Experimental animals
This study utilized progeny of Sprague-Dawley (SD) rats
(male, 9 - 11 weeks old) obtained from Experimental
Animal Center, Hallym University, Chunchon, South
Korea. The animals were provided with a commercial
diet and water ad libitum under controlled temperature,
humidity and lighting conditions (22 ± 2°C, 55 ± 5%
and a 12:12 light/dark cycle with lights). Animal proto-
cols were approved by the Institutional Animal Care
and Use Committee of Hallym University. Procedures
involving animals and their care were conducted in
accord with our institutional guidelines that comply
with NIH Guide for the Care and Use of Laboratory
Animals (NIH Publications No. 80-23, 1996). In addi-
t i o n ,w eh a v em a d ea l le f f o r t st om i n i m i z et h en u m b e r
of animals used and their suffering.
Intracerebroventricular drug infusion
Rats were divided into two groups: vehicle (saline)-treated
and soluble TNFp55 receptor (sTNFp55R, 50 μg/ml;
Sigma-Aldrich Co., St. Louis, MO)-treated groups. The
dosage of sTNFp55R was determined as the highest dose
that induced SE of comparable severity in 100% of animals
with 5% mortality in the preliminary study. Animals were
anesthetized (Zolretil, 50 mg/kg, i.m.; Virbac Laboratories,
France) and placed in a stereotaxic frames. For the osmotic
pump implantation, holes were drilled through the skull to
introduce a brain infusion kit 1 (Alzet, Cupertino, CA) into
the right lateral ventricle (1 mm posterior; 1.5 mm lateral; -
3.5 mm depth; flat skull position with bregma as reference),
according to the atlas of Paxinos and Watson [24]. The
infusion kit was sealed with dental cement and connected
to an osmotic pump (1007D, Alzet, Cupertino, CA). The
pump was placed in a subcutaneous pocket in the dorsal
region. Animals received 0.5 μl/hr of vehicle or compound
for 1 week. Therefore, the dose of sTNFp55R was 0.6 μg/
day per each animal. The compounds began to be immedi-
ately infused after surgery. Since the volume of vasogenic
edema peaked at 2-3 days after SE in our previous studies
[5-8,20], we chose this time point. Thus, our experimental
schedules at least inhibit the function of TNF-a from 3
days prior to SE to 4 days after SE when the volume of
vasogenic edema peaked.
Seizure induction
Three days after surgery, rats were treated with pilocar-
pine (380 mg/kg, i.p.; Sigma-Aldrich Co., St. Louis, MO)
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Sigma-Aldrich Co., St. Louis, MO). Using this treatment
paradigm, behavioral seizures typically began within 20-
40 min. Approximately 80% of pilocarpine treated rats
showed acute behavioral features of SE (including akine-
sia, facial automatisms, limbic seizures consisting of
forelimb clonus with rearing, salivation, masticatory jaw
movements, and falling). We applied the 2 hr-SE rat
model, because > 90% of the rats that we monitored in
our previous studies [25] displayed spontaneous, recur-
rent seizures within 1-3 months after pilocarpine-
induced status epilepticus. Diazepam (10 mg/kg, i.p.;
Hoffman Ia Roche, Neuilly sur-Seine) was administered
2 hours after onset of SE and repeated, as needed. The
rats were then observed 3 - 4 hours a day in the vivar-
ium for general behavior and occurrence of spontaneous
seizures. Non-experienced SE (non-SE) rats (showing
only acute seizure behaviors during 10 - 30 min, n = 8)
and age-matched normal rats were used as controls (n =
7).
Tissue processing
At designated time points (non-SE: 12 hr, 1 day, 2 days,
3 days, 4 days and 1 week after SE; n = 5, for each time
point), animals were perfused transcardially with phos-
phate-buffered saline (PBS) followed by 4% paraformal-
dehyde in 0.1 M phosphate buffer (PB, pH 7.4) under
urethane anesthesia (1.5 g/kg, i.p.; Sigma-Aldrich Co.,
St. Louis, MO). The brains were removed, and postfixed
i nt h es a m ef i x a t i v ef o r4h r .T h eb r a i nt i s s u e sw e r e
cryoprotected by infiltration with 30% sucrose overnight.
Thereafter, the entire hippocampus was frozen and sec-
tioned with a cryostat at 30 μm and consecutive sections
were contained in six-well plates containing PBS. For
stereological study, every sixth section in the series
throughout the entire hippocampus was used in some
animals.
Immunohistochemistry
Free-floating sections were first incubated with 10% nor-
mal goat serum for 30 min at room temperature. They
were then incubated in rabbit anti-MPO IgG (1:100,
Thermo fisher scientific) or rabbit anti-MIP-2 IgG
(1:200, Invitrogen, Carlsbad, CA) in PBS containing
0.3% Triton X-100 (Sigma-Aldrich Co., St. Louis, MO)
and 2% normal goat serum(Sigma-Aldrich Co., St. Louis,
MO) overnight at room temperature. After washing
three times for 10 min with PBS, the sections were incu-
bated sequentially, in goat anti-rabbit or horse anti-
mouse IgG (Vector, Burlingame, CA) and ABC complex
(Vector, Burlingame, CA), diluted 1:200 in the same
solution as the primary antiserum. Between the incuba-
tions, the tissues were washed with PBS three times for
10 min each. To confirm vasogenic edema, some tissue
sections were reacted for serum-proteins using horse
anti-rat IgG (Vector, Burlingame, CA) as a primary anti-
body. The sections were visualized with 3,3’-diamino-
benzidine (DAB, Sigma-Aldrich Co., St. Louis, MO) in
0.1 M Tris buffer and mounted on the gelatin-coated
slides. The immunoreactions were observed under the
Axioscope microscope (Carl Zeiss, Munchen-Hallberg-
moos). For negative controls, rat hippocampal tissues
were incubated with 1 μg of the antibody that was pre-
incubated with 1 μg of purified peptide for 1 hr at room
temperature or incubated with pre-immune serum
instead of the primary antibody. For negative controls,
tissues were incubated with pre-immune serum instead
of primary antibody.
Double immunofluorescence study
Sections were incubated with 3% bovine serum albumin
in PBS for 30 min at room temperature. Sections were
then incubated in a mixture of goat anti-TNF-a IgG
(1:1000, R&D systems, Minneapolis, MN)/mouse anti-
OX-42 IgG (1:100, Serotec, Cambridge, UK), mouse
anti-GFAP IgG (1:1000, an astroglial marker, Millipore
Corporation, Billerica, MA)/rabbit anti-TNFp55R IgG
(1:1000, Abcam, Cambridge, UK), mouse anti-GFAP
IgG/rabbit anti-TNFp75R IgG (1:1000, Abcam, Cam-
bridge, UK), mouse anti-SMI-71 IgM (1:1000, Covance,
Berkeley, CA)/rabbit anti-TNFp75R IgG, mouse anti-
GFAP IgG/rabbit anti-NF-B (p65-Ser276, p65-Ser311,
p65-Ser529, and p65-Thr435) IgG (1:100, Abcam, Cam-
bridge, UK), mouse anti-SMI-71 IgM/rabbit anti-p65-
Thr435 NF-B IgG, mouse anti-SMI-71 IgM/rabbit
a n t i - G L U T - 1I g G( 1 : 1 0 0 ,A b c a m ,C a m b r i d g e ,U K ) ,o r
mouse anti-GFAP IgG/rabbit anti-MIP-2 IgG (1:100) in
PBS containing 0.3% triton X-100 overnight at room
temperature. After washing three times for 10 minutes
with PBS, sections were also incubated in a mixture of
FITC- and Cy3-conjugated secondary antisera (Amer-
sham, San Francisco, CA), diluted 1:200, for 2 hr at
room temperature. The sections were washed three
times for 10 min with PBS, and mounted on gelatin-
coated slides. For nuclei counterstaining, we used Vecta-
shield mounting medium with DAPI (Vector, Burlin-
game, CA). All images were captured using an
AxioImage M2 microscope and AxioVision Rel. 4.8
software.
Fluoro-Jade B staining
Fluoro-Jade B (FJB) staining was used to identify degen-
erating neurons in tissues obtained from non-SE and 3
days post-SE animals in every group. In our previous
[18,25] and preliminary data, neuronal damage was first
detectable at 3 days after SE. Therefore, we determined
3 days after SE as the best time point to look FJB.
Briefly, sections were rinsed in distilled water, and
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slide warmer. The slides were immersed in 100% etha-
nol for 3 min, followed by 70% ethanol for 2 min and
distilled water for 2 min. The slides were then trans-
ferred to 0.06% potassium permanganate for 15 min and
gently agitated. After rinsing in distilled water for 2 min,
the slides were incubated for 30 min in 0.001% FJB
(Histo-Chem Inc., Jefferson, AR), freshly prepared by
adding 20 ml of a 0.01% stock FJB solution to 180 ml of
0.1% acetic acid, with gentle shaking in the dark. After
rinsing for 1 min in each of three changes of distilled
water, the slides were dried, dehydrated in xylene and
coverslipped with DPX (Sigma-Aldrich Co., St. Louis,
MO). For stereological study, every sixth section in the
series throughout the entire PC was used (see below).
Volumetric analysis and cell counts
To measure vasogenic edema, the volume of anti-rat
IgG positive region in PC was estimated according to
the formula based on the modified Cavalieri method: V
= Σa × tnom × 1/ssf, where a is area of the region of the
delineated subfield measured by AxioVision Rel. 4.8
software, tnom is the nominal section thickness (of 30
μm in this study), and ssf is the fraction of the sections
sampled or section sampling fraction (of 1/6 in this
study). The subfield areas were delineated with a 2.5 ×
objective lens [5,7,8,18,25]. The volumes are reported as
mm
3. An optical fractionator was used to estimate cell
numbers. The optical fractionator (a combination of
performing counting with the optical dissector, with
fractionator sampling) is a stereological method based
o nap r o p e r l yd e s i g n e ds y s t e m a t i cr a n d o ms a m p l i n g
method that by definition yields unbiased estimates of
population number. The sampling procedure is accom-
plished by focusing through the depth of the tissue (the
optical dissector height, h; 15 μm in all cases for this
study). The number of each cell type (C) in each of the
subregions is estimated as: C = ΣQ
- ×t / h×1 / a s f×1 /
ssf, where Q
- is the number of cells actually counted in
the dissectors that fell within the sectional profiles of
the subregion seen on the sampled sections, and Asf is
the areal sampling fraction calculated by the area of the
counting frame of the dissector, a(frame) (of 50 × 50
μm
2 in this study) and the area associated with each x, y
movement, grid (x, y step) (of 250 × 250 μm
2 in this
study) {asf = (a(frame)/a(x, y step))}. The immunoreac-
tive cells were counted with a 40× objective lens. The
immunoreactive cells were counted with a 40× objective
lens. All immunoreactive cells were counted regardless
the intensity of labeling. Cell counts were performed by
two different investigators who were blind to the classi-
fication of tissues. SE-induced PC atrophy is evident [8],
so changes in cell number may be caused by an altera-
tions in the volume of the PC. Therefore, the total
number of cells was corrected by multiplying with
appropriate correction factors (CF) representing the
degree of shrinkage (or swelling) compared with the
Non-SE.
Quantification of data
The fluorescence intensities of SMI-71/p65-Thr435
phosphorylation or GFPA/p65-Thr435 phosphorylation
were measured using a computer-assisted image analysis
p r o g r a m( T h eU n i v e r s i t yo f Texas ImageTool program
V. 3.0 and AxioVision Rel. 4.8 software). After regions
were outlined, 30 areas/rat (300 μm
2/area) were ran-
domly selected within the PC, and double immunofluor-
escent merge images were captured from the PC (15
sections from each animal). Merge images were digitally
separated to red or green image, and converted to grays-
cale images, respectively (n = 36 per region examined, in
non-SE, 12 hr post-SE and 1 day post-SE). The range of
intensity values was obtained from the selected images.
Based on the mean range of intensity values, each image
was normalized by adjusting the black and white range
of the image. Manipulation of the images was restricted
to threshold and brightness adjustments to the whole
image. Intensity measurements are represented as the
mean number of a 256 gray scale (NIH Image 1.59 soft-
ware and AxioVision Rel. 4.8 software). Values for back-
ground staining were obtained from the corpus
callosum. Optical density values were then corrected by
subtracting the average values of background noise
obtained from 15 image inputs.
Data analysis
Data obtained from volumetric analysis, cell counts, and
quantitative measurements were analyzed using Stu-
dent’s t-test to determine statistical significance. Linear
regression analysis was also performed to determine cor-
relations with SMI-71/p65-Thr435 phosphorylation, and
the number of MPO cells/vasogenic edema areas.
Results
TNF-a, and TNF receptor expression
In non-SE induced animals of the saline-infused groups,
TNF-a immunoreactivity was weakly detected in PC
neurons (data not shown). In 12 hr-post SE animals of
the saline-infused group, most of the activated microglia
showed strong TNF-a immunoreactivity (Figure 1A).
This expression pattern was maintained up to 1 week
after SE. In non-SE-induced animals of the saline-
infused groups, TNFp55R and TNFp75R immunoreac-
tivities were also weakly observed in astrocytes (data not
shown). In 12 hr-post SE animals of the saline-infused
group, TNFp55R immunoreactivity was observed in
astrocytes (Figure 1B). Unlike TNFp55R, TNFp75R
immunoreactivity was detected in endothelial cells as
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after SE, both TNFp55R and TNFp75R immunoreactiv-
ities were significantly reduced in astrocytes, not in
endothelial cells, due to massive astroglial loss (data not
shown) [5,7,8,20].
Effect of sTNFp55R infusion on SE-induced serum-protein
extravasation and neuronal damage
In our previous [5,7,8,20] and preliminary data, vaso-
genic edema and neuronal damage were noticeable at 1
day and 3 days after SE, respectively. Therefore, we
determined that 3 days after SE was the best time point
to evaluate the effect of sTNFp55R infusion on both
vasogenic edema and neuronal damages induced by SE.
In saline-treated animals, the PC was stained diffusely
with anti-rat IgG (Figure 2A). The volume of vasogenic
edema was 17.1 ± 1.5 mm
3 (Figure 2E). The number of
FJB-positive neurons in the PC was 236,145 ± 49,469
(Figure 2B). In sTNFp55R-treated animals, SE-induced
vasogenic edema was attenuated to 9.8 ± 0.7 mm
3 (Fig-
ures 2C and 2E). In addition, the number of FJB-positive
neurons in the PC was 89,138 ± 5,698 (Figures 2D-E).
Thus, sTNFp55R infusion attenuated SE-induced vaso-
genic edema and neuronal damage compared to saline-
infused animals (p < 0.05).
NF-B phosphorylation
It is well established that TNF-a is one of the major sti-
muli toward phosphorylation of NF-B. To confirm
TNF-a-mediated signaling following SE, we performed
an immunohistochemical study using five phospho-NF-
B antibodies. Compared to non-SE animals (data not
shown), 12 hr-post SE animals of the saline-infused
group showed p65-Ser276, p65-Ser311, p65-Ser529, and
p65-Ser536 phosphorylation in astrocytes (not endothe-
lial cells). sTNFp55R infusion effectively reduced p65-
Ser276 and p65-Ser311 phosphorylation (p < 0.05,
respectively), while it could not affect p65-Ser529 or
Figure 1 Expression of TNF-a and TNF receptor in the PC 12 hr-post SE.( A )T N F - a immunoreactivity in Ox-42-positive microglia (arrows).
(B) TNFp55R expression in astrocytes (arrows). (C-D) TNFp75R expression in astrocytes as well as endothelial cells (arrows). Bar = 25 (A-D) μm.
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Page 5 of 13Figure 2 Effect of sTNFp55R infusion on SE-induced serum-protein extravasation and neuronal damage.( A-D)S e r u m - p r o t e i n
extravasation and FJB-positive neuronal damages in the PC 3 days after SE. Compared to saline-infused animals, serum-protein extravasation and
FJB-positive neuronal damage is markedly ameliorated in sTNFp55R-infused animals. Bars = 400 (A and C) and 50 (B and D) μm. (E) Quantitative
analyses of serum-protein extravasation and FJB-positive neuronal damage in the PC 3 days after SE (mean ± S.E.M). Significant differences from
saline-treated animals, *p < 0.05.
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Page 6 of 13p65-Ser536 phosphorylation (Figures 3 and 4A). In con-
trast, p65-Thr435 phosphorylation was increased in
endothelial cells (not astrocytes) within the PC of saline-
infused animals 12 hr after SE (Figure 5A). In addition,
sTNFp55R infusion effectively alleviated SE-induced
p65-Thr435 phosphorylation in endothelial cells, com-
pared to saline infusion (p < 0.05, Figure 5B).
SMI-71 expression
Previously, we reported that SMI-71 (an endothelial bar-
rier antigen) immunoreactivity decreased in the PC 1
day after SE [5]. Similarly, in 1 day-post SE animals of
the saline-infused group, loss of SMI-71 immunoreactiv-
ity was detected in layer III/IV of the PC as compared
to non-SE animals (Figures 4B and 5C-E, p < 0.05).
T h u s ,l o s so fS M I - 7 1i m m u n o r e activity correlated with
volume of vasogenic edema following SE. This reduction
in SMI-71 was accompanied by increased p65-Thr435
phosphorylation (Figures 5C-D). Therefore, the degree
of SMI-71 immunoreactivity was inversely correlated to
p65-Thr435 phosphorylation with a linear coefficient of
correlation of -0.6324 (p < 0.05; Figure 4C). In addition,
sTNFp55R infusion effectively alleviated p65-Thr435
phosphorylation and preserved SMI-71 immunoreactiv-
ity in endothelial cells following SE, as compared to sal-
ine infusion (p < 0.05; Figures 4A-B, 5D and 5F).
Neutrophil infiltration
Recent studies have reported that neutrophils infiltrate
the brain under certain pathological conditions [26].
Indeed, we have reported massive neutrophil infiltration
in layer III/IV of the PC 1 day after SE [20]. In the pre-
sent study, 1 day-post-SE animals of the saline-infused
group showed infiltration of MPO-positive neutrophils
into the PC. Similarly, 1 day-post-SE animals of the
sTNFp55R-infused group showed neutrophil infiltration
into the PC 1 day after SE (Figure 6A). The number of
neutrophils/area in the PC region (including the vaso-
genic edema region and the non-vasogenic edema
region) of sTNFp55R-infused animals was significantly
lower than that of the saline-infused group (Figure 6D,
p < 0.05). However, there was no difference in neutro-
phil infiltration per unit area of vasogenic edema
between the saline- and sTNFp55R-infused groups (Fig-
ure 6D). Furthermore, neutrophil infiltration showed a
direct proportion to the area of vasogenic edema, with a
linear coefficient of correlation of 0.8631 (p < 0.05, Fig-
ure 6E). Therefore, our findings indicate that SE-
induced neutrophil infiltration into the PC may be cor-
related to TNF-a-mediated vasogenic edema formation.
MIP-2 expression
MIP-2 is a powerful chemokine that contributes to
recruitment of neutrophils [27]. MIP-2 is undetectable
or present at low levels under physiological conditions,
and shows transient increases under pathological condi-
tions via TNF-a and/or interleukin-1b (IL-1b)-depen-
dent mechanisms [14]. Thus, it would be plausible that
TNF-a-mediated MIP-2 expression may provoke SE-
induced neutrophil infiltrations. To confirm this hypoth-
esis, we investigated MIP-2 expression in the PC. Con-
sistent with our previous study [20], some MIP-2-
positive astrocytes were observed in the core and per-
iphery of the vasogenic edema lesions, but not in the
non-vasogenic edema region (Figure 6B and 6C).
Although the number of MIP-2 positive cells per unit
area in the PC region of sTNFp55R-infused animals was
significantly lower than that of the saline-infused group
due to reduction of the area of vasogenic edema, there
was no difference in the number of MIP-2 positive cells
per unit area of vasogenic edema between sTNFp55R-
i n f u s e da n i m a l sa n ds a l i n e - i n f u s e da n i m a l s( F i g u r e6 F ) .
Furthermore, the number of MIP-2-positive cells
showed a direct proportion to the unit area of vasogenic
edema with a linear coefficient of correlation of 0.682 (p
< 0.05, Figure 6G). Therefore, together with reduction
in neutrophil infiltration in the PC region of sTNFp55R-
infused animals, our findings provide evidence that
TNF-a may regulate SE-induced neutrophil infiltration
at least in the PC via vasogenic edema formation and
not via direct TNF-a-mediated MIP-2 expression in
astrocytes.
Discussion
The major findings in the present study are that TNF-a
signaling showed cellular specific responses of NF-B
phosphorylation in the PC following SE, which may be
related to vasogenic edema formation followed by neu-
trophil infiltration. BBB disruption has been reported in
experimental and human epilepsy [12,13,15,16,28]. Leak-
age of serum-derived components into the extracellular
space is associated with hyperexcitability and seizure
onset [12,13,15,16,28]. Furthermore, dysfunction of the
BBB leads to epileptogenesis and contributes to progres-
sion of epilepsy [12,13,15,16,28]. In the present study,
TNF-a immunoreactivity was obviously observed in
microglia in the PC following SE. TNF receptor expres-
sions were also up-regulated in astrocytes (TNFp55R
and TNFp75R) and endothelial cells (TNFp75R).
Furthermore, blockade of TNF-a signaling by sTNFp55
infusion effectively (but not completely) reduced
volumes of SE-induced vasogenic edema and neuronal
d a m a g ei nt h eP C .T h e s ef i n d i n g si n d i c a t et h a tT N F - a
may participate in astroglial and endothelial responses
to SE, which are relevant to SE-induced vasogenic
edema formation [5-8]. Indeed, TNF-a signaling
increases BBB permeability in various experimental dis-
ease models [29]. In the present study, sTNFp55
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Page 7 of 13Figure 3 Effect of sTNFp55R infusion on NF-B phosphorylation in astrocytes 12 hr after SE. In 12 hr-post SE animals of the saline-infused
group (A, C, E and G), astrocytes show p65-Ser276 (A), p65-Ser311 (C), p65-Ser529 (E), and p65-Ser536 (G) phosphorylation (arrows). sTNFp55R
infusion (B, D, F and H) effectively reduces p65-Ser276 (B) and p65-Ser311 (D) phosphorylation, while it does not affect p65-Ser529 (F) and p65-
Ser536 (H) phosphorylation (arrows). Bar = 12.5 μm.
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Page 8 of 13infusion could not completely prevent SE-induced vaso-
genic edema and neuronal damage in the PC. Therefore,
our findings suggest that TNF-a signaling may not be a
unique upstream event in vasogenic edema
development.
p65 phosphorylation of NF-B enhances its transacti-
vation potential, and p65 phosphorylation occurs in
either the cytoplasm or the nucleus [30]. In the present
study, p65-Thr435 immunoreactivity was detected in
endothelial cells, and its immunoreactivity showed an
inverse correlation to the degree of SMI-71 expression.
SMI-71, an endothelial barrier antigen, is a protein
expressed by endothelial cells of rat BBB [31]. Under
pathological conditions, SMI-71 expression is lost in
endothelial cells [5,7,8,30,32]. Acute phases of the above
pathological conditions are accompanied by opening of
the BBB and development of vasogenic edema [33].
Indeed, neutralization of SMI-71 in vivo leads to widen-
ing of intercellular junctions between endothelial cells
and swelling of perivascular astrocytic processes [34],
although SMI-71 is not localized at endothelial cell
junctions [35-38]. In the present study, SMI-71 immu-
noreactivity was significantly reduced in blood vessels 1
day after SE when vasogenic edema and neuronal
damage were observed. Furthermore, sTNFp55R infu-
sion effectively prevented SE-induced SMI-71 down-reg-
ulation. With respect to the phosphorylation of p65-
Thr435 by TNF-a [39], our findings indicate that TNF-
a-mediated p65-Thr435 phosphorylation in endothelial
cells may play an important role in vasogenic edema
induction via SMI-71 degradation or its posttranslational
dysfunction influencing BBB permeability.
In our previous studies [5,8], dystrophin (an actin-
binding protein [40]) immunoreactivity was detected in
blood vessels and in astrocytic perivascular end-feet, and
was down-regulated 12 hrs after SE prior to the appear-
ance of vasogenic edema and down-regulation of SMI-
71 immunoreactivity. With respect to this previous
report, changes in SMI immunoreactivity would be
causes/results of interaction between endothelial cells
and perivascular astrocytes. In the present study, p65-
Ser276, p65-Ser311, p65-Ser529, and p65-Ser536 phos-
phorylation was observed in astrocytes following SE.
Furthermore, sTNFp55R infusion effectively inhibited
p65-Ser276 and p65-Ser311phosphorylation in astro-
cytes following SE. Therefore, it is likely that enhanced
Figure 4 Quantitative analyses of the effect of sTNFp55R infusion on NF-B phosphorylation and SMI-71 expression.( A) Quantitative
analysis of NF-B phosphorylation 12 hr after SE (mean ± S.E.M). Significant differences from saline-infused animals, *p < 0.05. (B) Quantitative
analysis of SMI-71 expression 1 day after SE (mean ± S.E.M). Significant differences from saline-infused animals, *p < 0.05. (C) Linear regression
analysis between p65-Thr435 phosphorylation and SMI-71 in the PC following SE.
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Page 9 of 13Figure 5 Effect of sTNFp55R infusion on p65-Thr435 phosphorylation in endothelial cells following SE.( A-B) Inhibition of p65-Thr435
phosphorylation by sTNFp55R infusion 12 hr after SE. p65-Thr435 phosphorylation is rarely observed in astrocytes (arrows). (C) Endothelial p65-
Thr435 phosphorylation in non-SE animals. (D-E) Endothelial p65-Thr435 phosphorylation in saline-infused animals 1 day after SE. p65-Thr435
phosphorylation is enhanced, while SMI-71 expression is reduced in GLUT-1-positive endothelial cells (arrows). (F-G) Endothelial p65-Thr435
phosphorylation in sTNFp55R-infused animal 1 day after SE. sTNFp55R infusion effectively reduces p65-Thr435 and preserves SMI-71 expression in
GLUT-1-positive endothelial cells (arrows). Bars = 12.5 (A-D) and 25 (E-G) μm.
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Page 10 of 13Figure 6 Effect of sTNFp55R infusion on neutrophil infiltration and MIP-2 expression following SE.( A) Neutrophil infiltration in vasogenic
edema lesion 1 day after SE. (B) MIP-2 expression in the PC 1 day after SE. (C) Astroglial expression of MIP-2 (arrows). Bars = 12.5 (A and C) and
150 (B) μm. (D) Quantitative analysis of neutrophil infiltration 1 day after SE (mean ± S.E.M). Significant differences from saline-infused animals, *p
< 0.05. (E) Linear regression analysis between the number of infiltrated neutrophils/area in the vasogenic edema region and the area of
vasogenic edema in the PC. (F) Quantitative analysis of the number of MIP-2 positive cells per the unit area of vasogenic edema 1 day after SE
(mean ± S.E.M). There is no difference in the number of MIP-2-positive cells per unit area of vasogenic edema between sTNFp55R-infused
animals and saline-infused animals. (G) Linear regression analysis between the number of MIP-2 positive cells per unit area in vasogenic edema
region and the area of vasogenic edema in the PC.
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Page 11 of 13p65-Ser276 and p65-Ser311 phosphorylation may be
involved in TNF-a-mediated BBB disruption. However,
sTNFp55R infusion could not prevent p65-Ser529 and
p65-Ser536 phosphorylations from SE insults. Since
p65-Ser529 and p65-Ser536 are phosphorylated by TNF-
a and IL-1b [41], it is likely that IL-1b-mediated p65-
Ser529/Ser536 phosphorylation may also play a role in
SE-induced vasogenic edema. Therefore, our findings
indicate that both TNF-a and IL-1b m a yb es y n e r g i s t s
to play either a direct (by endothelial cells) or indirect
(by astrocytes) role in the maintenance of BBB
permeability.
Neutrophil infiltration into brain parenchyma is tran-
siently observed during the acute phase of SE (4 - 36 hr
after SE) and disappears thereafter [20]. SE rapidly
increases synthesis and release of chemokines in various
areas of the rodent brain [42]. Among them, MIP-2 is
required for efficient neutrophil or lymphocyte recruit-
ment to brain parenchyma [43]. In our previous study
[20], neutrophil infiltration in the frontoparietal cortex
was regulated by P2X7 receptor-mediated MIP-2 expres-
sion. In the PC, however, neither a P2X7 receptor ago-
nist/antagonist nor IL-1Ra (an IL-1b antagonist)
infusion could not affect leukocyte infiltration. In the
present study, sTNFp55R infusion effectively inhibited
neutrophil infiltration in the PC by reducing vasogenic
edema formation in a MIP-2-independent manner. With
respect to the present and our previous reports, it is
therefore likely that vasogenic edema induced by TNF-a
can induce neutrophil infiltration and press injury to
evoke neuronal-astroglial loss in the PC, unlike other
brain regions.
In conclusion, our findings reveal that impairments of
endothelial cell function via TNF-a mediated p65-Thr
435 NF-B phosphorylation may be involved in SE-
induced vasogenic edema, which is relevant to neutro-
phil infiltration and neuronal-astroglial loss.
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